Skip to main content
Fig. 2 | BMC Oral Health

Fig. 2

From: Evaluation of topical erythropoietin application on the healing outcome of gingival graft recipient site; a randomized controlled clinical trial

Fig. 2

a Baseline FGG treatment EPO group, b baseline FGG treatment control group, c 7 days postop EPO group, d 7 days postop control group, e 14 days postop EPO group, f 14 days postop control group, g 21 days postop EPO group, h 21 days postop control group, i 28 days postop EPO group, j 28 days postop control group, k 60 days postop EPO group, l 60 days postop control group, m 90 days postop EPO group, n 90 days postop control group

Back to article page

BMC Oral Health

ISSN: 1472-6831

Contact us